Regentis’ GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Ac…

This rare outcome in cartilage repair suggests true biological cartilage regeneration, not merely defect filling Unlike ...
Earth.com

Scientists restore knee cartilage using targeted injection

An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.

Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical Programs

New clinical sites to support engagement with leading orthopedic surgeons and centers of excellence in key European markets, ...

Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

MEDIPOST Inc. Submits IND Amendment With U.S. Food and Drug Administration to Initiate Phase III Trial

MEDIPOST's investigational therapy is an umbilical cord blood-derived allogeneic mesenchymal stem cell therapy designed to treat symptomatic cartilage defects in patients with knee osteoarthritis.

MEDIPOST files IND amendment to FDA for Phase III osteoarthritis trial

MEDIPOST has submitted an investigational new drug (IND) amendment to the US Food and Drug Administration (FDA) to initiate a ...
Becker's Spine Review

Atlanta clinic debuts offering regenerative treatments for spine, joints

CartiNova, a regenerative medicine clinic focused on orthopedic and spine care, has launched in Atlanta. Founded by Trevor Turner, MD, a regenerative orthopedics physician, the practice offers ...
Morningstar

Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC

GerlinC is in a pivotal FDA trial, has received regulatory approval in the EU, and is the world's first off-the-shelf regenerative treatment for knee cartilage repair HERZLIYA, IL / ACCESS Newswire / ...
Morningstar

Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method

HERZLIYA, IL / ACCESS Newswire / January 20, 2026 / Regentis Biomaterials Ltd., ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair ...